Cue Biopharma CEO Usman Azam resigns; Lucinda Warren named Interim CEO

Cue Biopharma, Inc.

Usman Azam resigned as President, CEO and Board member effective March 26, 2026.
Lucinda Warren, previously CFO and CBO, appointed Interim President and CEO effective March 27, 2026; retains CFO and CBO roles.
Warren's base salary $525,000; eligible for 45% target bonus and up to 1.0% stock option upon financing milestone.
Azam severance: lump sum $232,500 (3 months salary plus 25% of 2026 target bonus) plus up to 12 months COBRA.
Warren receives $10,000/month supplemental until new CEO hired or 12-month anniversary, with lump sum if earlier.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.